Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections
Status:
Completed
Trial end date:
2010-05-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetic profile
of an antibacterial compound for treatment of hospital acquired Gram negative infection.